170 related articles for article (PubMed ID: 3901214)
21. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections.
Keller CA; Villavicencio J; Ramirez C
Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287
[TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of imipenem/cilastatin sodium in the pediatric field].
Hirosawa H; Hoshina H; Morikawa Y; Ichihashi H
Jpn J Antibiot; 1986 Jul; 39(7):1733-44. PubMed ID: 3464776
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
[TBL] [Abstract][Full Text] [Related]
24. Imipenem/cilastatin therapy for serious infections in neonates and infants.
Nalin DR; Jacobsen CA
Scand J Infect Dis Suppl; 1987; 52():46-55. PubMed ID: 3331042
[TBL] [Abstract][Full Text] [Related]
25. Randomized trial of imipenem/cilastatin versus gentamicin and clindamycin in mixed flora infections.
Solomkin JS; Fant WK; Rivera JO; Alexander JW
Am J Med; 1985 Jun; 78(6A):85-91. PubMed ID: 3890538
[TBL] [Abstract][Full Text] [Related]
26. Effect of imipenem/cilastatin on the colonic microflora.
Nord CE; Kager L; Philipson A; Stiernstedt G
Rev Infect Dis; 1985; 7 Suppl 3():S432-4. PubMed ID: 3863218
[TBL] [Abstract][Full Text] [Related]
27. Imipenem/cilastatin therapy of infections in cancer patients.
Bodey GP; Elting L; Jones P; Alvarez ME; Rolston K; Fainstein V
Cancer; 1987 Jul; 60(2):255-62. PubMed ID: 3297282
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of high-dose treatment with imipenem-cilastatin in seriously ill patients.
Zajac BA; Fisher MA; Gibson GA; MacGregor RR
Antimicrob Agents Chemother; 1985 May; 27(5):745-8. PubMed ID: 3860187
[TBL] [Abstract][Full Text] [Related]
29. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
30. [Laboratory and clinical studies of imipenem/cilastatin sodium in the pediatric field].
Nishimura T; Tabuki K; Takashima T; Takagi M
Jpn J Antibiot; 1986 Jul; 39(7):1867-78. PubMed ID: 3464783
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and pharmacokinetic evaluation of imipenem/cilastatin sodium in children].
Fujita K; Kakehashi H; Murono K; Sakata H; Ohmi H; Yoshioka H; Maruyama S; Sanae N; Inyaku F
Jpn J Antibiot; 1986 Jul; 39(7):1681-92. PubMed ID: 3464772
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of imipenem/cilastatin sodium in children].
Meguro H; Arimasu O; Kobayashi M; Shiraishi H; Fujii R; Izumi K
Jpn J Antibiot; 1986 Jul; 39(7):1715-32. PubMed ID: 3464775
[TBL] [Abstract][Full Text] [Related]
33. Imipenem/cilastatin in the treatment of osteomyelitis.
MacGregor RR; Gentry LO
Am J Med; 1985 Jun; 78(6A):100-3. PubMed ID: 3859207
[TBL] [Abstract][Full Text] [Related]
34. [A clinical study on imipenem/cilastatin sodium in the field of pediatrics].
Satoh K; Watanabe A
Jpn J Antibiot; 1986 Jul; 39(7):1701-7. PubMed ID: 3534345
[TBL] [Abstract][Full Text] [Related]
35. Imipenem/cilastatin: rationale for a fixed combination.
Norrby SR
Rev Infect Dis; 1985; 7 Suppl 3():S447-51. PubMed ID: 3863220
[TBL] [Abstract][Full Text] [Related]
36. [Fundamental and clinical evaluation of imipenem/cilastatin sodium in the field of pediatrics].
Haruta T; Okura KE; Kuroki S; Yamamoto H; Yamaoka K; Kubo K; Kobayashi Y
Jpn J Antibiot; 1986 Jul; 39(7):1879-88. PubMed ID: 2945941
[TBL] [Abstract][Full Text] [Related]
37. [A clinical evaluation of MK-0787/MK-0791 for long-term administration in urological infections].
Suzuki K; Takanashi K; Naide Y; Fujita T; Ogawa T; Hirabayashi S; Tamai H; Yanaoka M; Ishiguro K; Asano H
Hinyokika Kiyo; 1986 Sep; 32(9):1387-408. PubMed ID: 3101448
[TBL] [Abstract][Full Text] [Related]
38. The efficacy results and safety profile of imipenem/cilastatin from the clinical research trials.
Calandra GB; Ricci FM; Wang C; Brown KR
J Clin Pharmacol; 1988 Feb; 28(2):120-7. PubMed ID: 3283176
[TBL] [Abstract][Full Text] [Related]
39. Imipenem/cilastatin treatment of multiresistant Pseudomonas aeruginosa lung infection in cystic fibrosis.
Pedersen SS; Pressler T; Høiby N; Bentzon MW; Koch C
J Antimicrob Chemother; 1985 Nov; 16(5):629-35. PubMed ID: 3935639
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of respiratory tract infections with imipenem/cilastatin in critical patients with respiratory insufficiency].
Unertl K; Ruckdeschel G; Forst H; Lenhart FP
Infection; 1986; 14 Suppl 2():S176-80. PubMed ID: 3759253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
